Haw Par Corp. Ltd. is a pharmaceutical company based in Singapore with a medium ESG risk rating score of 29.0. The company focuses on expanding its core businesses through product brand extension, strategic alliances, and potential acquisitions. Haw Par operates in segments including Healthcare, Investments, and Others, with the Healthcare segment being its primary revenue generator. The Healthcare segment manufactures and distributes topical analgesic products under well-known brands like Tiger Balm and Kwan Loong, with a significant revenue contribution from ASEAN countries.